The much heralded drug Accomplia received an approvable letter yesterday. Sanofi-Aventis is confident they will have the drug approved in a short amount of time but surely is dissapointed. Accomplia is predicted to be a $3 billion drug. I will be keeping an eye on the stock on Tuesday and if it drops too much I will put in a buy.